Invivyd Financials
| IVVD Stock | USD 0.59 0.08 11.94% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.009 | 0.0122 |
|
| |||||
| Current Ratio | 4.25 | 4.4716 |
|
|
The financial analysis of Invivyd is a critical element in measuring its lifeblood. Investors should not minimize Invivyd's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Invivyd | Select Account or Indicator |
Understanding current and past Invivyd Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Invivyd's financial statements are interrelated, with each one affecting the others. For example, an increase in Invivyd's assets may result in an increase in income on the income statement.
Please note, the presentation of Invivyd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Invivyd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Invivyd's management manipulating its earnings.
Invivyd Stock Summary
Invivyd competes with Exscientia, Recursion Pharmaceuticals, Atea Pharmaceuticals, Unity Biotechnology, and Regenxbio. Invivyd, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Invivyd, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Invivyd operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 00534A102 |
| Location | Massachusetts; U.S.A |
| Business Address | 1601 Trapelo Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | invivyd.com |
| Phone | 781 819 0080 |
| Currency | USD - US Dollar |
Invivyd Key Financial Ratios
| Return On Equity | -0.97 | ||||
| Operating Margin | (21.75) % | ||||
| Price To Sales | 35.41 X | ||||
| EBITDA | (196.62 M) | ||||
| Net Income | (198.64 M) |
Invivyd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Invivyd's current stock value. Our valuation model uses many indicators to compare Invivyd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Invivyd competition to find correlations between indicators driving Invivyd's intrinsic value. More Info.Invivyd is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Invivyd's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Invivyd by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Invivyd Systematic Risk
Invivyd's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Invivyd volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Invivyd correlated with the market. If Beta is less than 0 Invivyd generally moves in the opposite direction as compared to the market. If Invivyd Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Invivyd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Invivyd is generally in the same direction as the market. If Beta > 1 Invivyd moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Invivyd Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Invivyd's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Invivyd growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Invivyd November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Invivyd help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Invivyd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Invivyd based on widely used predictive technical indicators. In general, we focus on analyzing Invivyd Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Invivyd's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 56.4 | |||
| Value At Risk | (11.30) | |||
| Potential Upside | 13.04 |
Complementary Tools for Invivyd Stock analysis
When running Invivyd's price analysis, check to measure Invivyd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invivyd is operating at the current time. Most of Invivyd's value examination focuses on studying past and present price action to predict the probability of Invivyd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invivyd's price. Additionally, you may evaluate how the addition of Invivyd to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |